Illumina Receives FDA 510(K) Clearance for Veracode(R) Genotyping Test for Factor V (Leiden) and Factor II (Prothrombin).
Illumina Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for the VeraCode(R) Genotyping Test for Factor V (Leiden) and Factor II (Prothrombin). The VeraCode Genotyping Test is comprised of the company's VeraCode digital microbead technology and proprietary assay chemistry. The BeadXpress(R) System, which received a separate 510(k) market clearance, is FDA-cleared for in vitro diagnostic use only with the VeraCode Genotyping Test for Factor V and Factor II.
